AbbVie (ABBV) Intangibles (2012 - 2026)
AbbVie's Intangibles came in at $49.14 billion for Q2 2026, down 13.8% from $57.03 billion a year earlier and down 3.4% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Intangibles (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie's Intangibles was $52.64 billion, down 12.4% from FY2024.
- Intangibles carries a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- Going back by year, Intangibles was $60.07 billion in FY2024 (+8.0%), $55.61 billion in FY2023 (-17.5%), $67.44 billion in FY2022 (-11.2%) and $75.95 billion in FY2021 (-8.4%).
- The Q2 2026 figure represents the lowest quarterly Intangibles since Q1 2020.
- Year-over-year, Intangibles has declined for six consecutive quarters, with an average decline of 5.9% over the last eight quarters.
- The fastest year-over-year change in Intangibles over five years came in Q3 2024 (growth of 13.7%), and the weakest in Q3 2025 (a decline of 18.5%).
- Business Quant data shows ABBV's Intangibles at $50.87 billion (Q1 2026), $52.64 billion (Q4 2025) and $54.32 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 412.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.14 Bn |
| Mar 31, 2026 | 50.87 Bn |
| Dec 31, 2025 | 52.64 Bn |
| Sep 30, 2025 | 54.32 Bn |
| Jun 30, 2025 | 57.03 Bn |
| Mar 31, 2025 | 58.49 Bn |
| Dec 31, 2024 | 60.07 Bn |
| Sep 30, 2024 | 66.65 Bn |
| Jun 30, 2024 | 60.24 Bn |
| Mar 31, 2024 | 62.23 Bn |
| Dec 31, 2023 | 55.61 Bn |
| Sep 30, 2023 | 58.60 Bn |
| Jun 30, 2023 | 62.86 Bn |
| Mar 31, 2023 | 64.85 Bn |
| Dec 31, 2022 | 67.44 Bn |
| Sep 30, 2022 | 68.73 Bn |
| Jun 30, 2022 | 71.82 Bn |
| Mar 31, 2022 | 73.99 Bn |
| Dec 31, 2021 | 75.95 Bn |
| Sep 30, 2021 | 77.46 Bn |
API Access
AbbVie Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();